港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

三生制药

23.000

-1.000-4.17%

成交量：6,999.32万

成交额：16.27亿

市值：551.77亿

市盈率：24.45

高：24.450

开：23.800

低：22.650

收：24.000

数据加载中...

总览公司新闻公告

三生制药股价飙涨32.28%：怎样一款“拳头产品”赢得了“宇宙大药厂”的心？

【热门行业】港股医药股集体走强创新出海驱动估值重构

港股概念追踪|三生制药PD-1/VEGF双抗首个三期临床启动头对头挑战K药（附概念股）

【券商聚焦】招银国际维持三生制药(01530)买入评级指授权交易将大幅增厚公司2025年利润

《大行》中银国际：与辉瑞合作规模超预期升三生制药(01530.HK)目标价至21.8元

阿斯达克财经

中信里昂：升三生制药(01530)目标价至19.6港元维持“跑赢大市”评级

60.5亿美元获三生制药PD-1/VEGF双抗权益，辉瑞这次真急了？

医药经济报

三生制药：60 亿美元交易，目标价上调

【大行评级丨招商证券国际：上调三生制药目标价至25港元维持“买入”评级】招商证券国际报告指，三生制药与辉瑞签署中国生物制药行业最大单一资产交易，预付款12.5亿美元，总规模60亿美元。报告指，该行于早前报告已提醒投资者关于PD-1xVEGF和TL1A的许可转让，预计免疫学资产的进一步成熟可能推动另一次估值升级，基于公司产品线丰富，目标今年至2027年推出约10款产品并提交新药申请，并持续扩展适应症，以及内部新型产品线和经验证业务拓展努力，脱发、皮肤病、自体免疫产品组合得到充实。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至25港元。

港股午评：恒指早间红盘震荡收涨0.53% 生物医药板块延续涨势

港股午评|恒生指数早盘涨0.53% 生物医药板块持续强势

《大行》里昂升三生制药(01530.HK)目标价至19.6元维持“跑赢大市”评级

阿斯达克财经

《大行》招证国际：三生制药(01530.HK)料受惠免疫学资产成熟目标价上调至25元

阿斯达克财经

康方生物早盘涨超7% 三生制药PD-1双抗出海刷新纪录

三生制药与辉瑞达成重磅授权交易，释放PD-1/VEGF的同类最佳潜力

《股市简讯》香港生物科技指数一度升3.5%，券商称持续看好中国创新药领域

中国创新药创记录BD交易的背后

三生制药创新合作释放增长潜力：双抗授权与核心品种驱动未来业绩

三生制药签下60亿美元大单，创新药概念今日延续强势，创新药沪港深ETF再度上涨超1.5%

21世纪经济报道

【券商聚焦】国信证券维持三生制药(01530)“优于大市”评级指公司自研和引进的管线即将进入收获期

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/01530/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01530\",,,,,undefined,":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":23,"timestamp":1749629290028,"preClose":24,"halted":0,"volume":69993156,"delay":0,"floatShares":2399000000,"shares":2399000000,"eps":0.9407602916895594,"marketStatus":"未开盘","change":-1,"latestTime":"06-11 16:08:10","open":23.8,"high":24.45,"low":22.65,"amount":1627348658,"amplitude":0.075,"askPrice":23,"askSize":125500,"bidPrice":22.95,"bidSize":314500,"shortable":3,"etf":0,"ttmEps":0.9271035116085585,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1749691800000},"marketStatusCode":0,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":24,"dividendRate":0.011159,"openAndCloseTimeList":[[1749605400000,1749614400000],[1749618000000,1749628800000]],"volumeRatio":1.093392016277921,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01530\",,,,,undefined,":{"symbol":"01530","floatShares":2399000000,"roa":"6.82%","roe":"12.84%","lyrEps":0.94076,"volumeRatio":1.093392016277921,"shares":2399000000,"dividePrice":0.256234,"high":24.45,"amplitude":0.075,"preClose":24,"low":22.65,"week52Low":5.47,"pbRate":"3.28","psRate":"5.55","week52High":24.95,"institutionHeld":0,"latestPrice":23,"committee":0.429545,"eps":0.9407602916895594,"divideRate":0.011141,"volume":69993156,"delay":0,"ttmEps":0.9271035116085585,"open":23.8,"prevYearClose":6.08,"prevWeekClose":20.2,"prevMonthClose":18.82,"prevQuarterClose":11.96,"fiveDayClose":19.64,"twentyDayClose":11.56,"sixtyDayClose":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01530\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537605140","title":"三生制药股价飙涨32.28%：怎样一款“拳头产品”赢得了“宇宙大药厂”的心？","url":"https://stock-news.laohu8.com/highlight/detail?id=2537605140","media":"钛媒体APP","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537605140?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 14:51","pubTimestamp":1747810280,"startTime":"0","endTime":"0","summary":"截至今日收盘，三生制药股价报19.18港元/股，上涨32.28%，成交额达46.34亿港元，总市值达460.05亿港元。另外，三生制药将获得12.5亿美元的不可退还且不可抵扣的首付款，以及最高可达48亿美元的开发、监管批准和销售里程碑付款。三生制药又有怎样的诉求？据财报，2024年，三生制药实现收入91.08亿元，同比增长6.53%；归母净利润20.9亿元，同比增长34.93%；经调整的经营性归母净利润约23.18亿元，同比增长18.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521150039a4866111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521150039a4866111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1593","BK1583","BK1161"],"gpt_icon":1},{"id":"2537082266","title":"【热门行业】港股医药股集体走强 创新出海驱动估值重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2537082266","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537082266?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 14:03","pubTimestamp":1747807396,"startTime":"0","endTime":"0","summary":"2024年度业绩暨现金分红说明会上，恒瑞医药称其创新药出海成效显着，目前，公司已实现13项创新药海外授权，交易总额约为140亿美元。“出海”已成为中国医药企业的重要战略。今年4月中美关税摩擦以来，仍有多项药品出海BD交易达成，显示创新药出海势头仍然强劲。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/NDdkYmY2NGUzZGQ4YzY5MzkwZTM0MzQwMzk2Mjg3Mzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NDdkYmY2NGUzZGQ4YzY5MzkwZTM0MzQwMzk2Mjg3Mzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959053","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK1219","09606","LU2328871848.SGD","IE0008369823.USD","159718","06160","LU1008478684.HKD","SG9999004311.SGD","BK1191","BK1583","IE00B5MMRT66.SGD","LU0067412154.USD","LU1993786604.SGD","01530","02367","IE00BZ08YT58.USD","LU0072913022.USD","01801","BK1161","BK1589","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1226288253.USD","09969","BK1574","LU1807302812.USD","LU1951186391.HKD","LU0588546209.SGD","LU1969619763.USD","LU0501845795.SGD","LU1226287875.USD","IE00B543WZ88.USD","BK1521","BK1207","LU1152091754.HKD","BK1515","03692","02561","01093","SG9999004220.SGD","LU2488822045.USD","BK1593","IE00B031HY20.USD","LU1152091168.USD","02105","BK1500","LU1226287529.USD","LU0880133367.SGD","02273"],"gpt_icon":1},{"id":"2537608163","title":"港股概念追踪|三生制药PD-1/VEGF双抗首个三期临床启动    头对头挑战K药（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2537608163","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537608163?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 14:00","pubTimestamp":1747807234,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年5月20日，三生制药在ClinicalTrials.gov注册了PD-1/VEGF双抗SSGJ-707的一项三期临床试验，用于一线治疗PD-L1阳性晚期非小细胞肺癌，这是该品种迈入的首个III期临床研究。辉瑞引进三生制药PD-1/VEGF双抗SSGJ-707是三生制药自主研发的创新药物，目前正在中国进行多项临床研究，包括已获批的PD-L1阳性局部晚期或转移性非小细胞肺癌Ⅲ期临床试验，并已获得中国突破性疗法认定。三生制药与辉瑞达成60亿美元天价授权合作，创下中国创新药BD交易新纪录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["YANG","LU0861579265.USD","LU2106854487.HKD","HSTECH","SG9999001176.SGD","LU0320765489.SGD","LU1794554557.SGD","LU0058720904.USD","LU1037948541.HKD","LU2324357040.USD","LU0965509283.SGD","LU2023250843.SGD","LU0266013472.USD","LU0070302665.USD","LU1116320737.USD","LU0265550946.USD","LU1023059063.AUD","IE00BLSP4452.SGD","LU2461242641.AUD","SG9999001176.USD","SG9999014559.SGD","LU1066051498.USD","LU1162221912.USD","LU1169589451.USD","LU1169590202.USD","HSCEI","LU1037948897.HKD","BK1574","LU1941712264.USD","LU1941712348.USD","PD","BK4533","LU1069347547.HKD","09926","BK4534","LU1934455863.HKD","01530","LU2112291526.USD","LU0965508806.USD","LU1057294990.SGD","LU0965509101.SGD","LU2361045086.USD","LU2361044865.SGD","IE00BJT1NW94.SGD","LU0238689110.USD","BK4588","LU1917777945.USD","LU1585245621.USD"],"gpt_icon":1},{"id":"2537082206","title":"【券商聚焦】招银国际维持三生制药(01530)买入评级 指授权交易将大幅增厚公司2025年利润","url":"https://stock-news.laohu8.com/highlight/detail?id=2537082206","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537082206?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 13:56","pubTimestamp":1747806978,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，三生制药 将707的全球权益授权给辉瑞，将获得12.5亿美元的首付款及最高达48亿美元的里程碑付款，并将获得双位数的产品销售分成，交易规模大幅超出市场预期。此外，授权交易达成后，辉瑞还将按30日成交量加权平均价认购公司1亿美元的普通股。该行续指，授权交易将大幅增厚公司2025年利润。三生制药合计控制三生国健80.88%的股权。予买入评级，目标价28.32港元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959052","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"gpt_icon":1},{"id":"2537530603","title":"《大行》中银国际：与辉瑞合作规模超预期 升三生制药(01530.HK)目标价至21.8元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537530603","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537530603?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 13:54","pubTimestamp":1747806840,"startTime":"0","endTime":"0","summary":"中银国际研究报告指，三生制药日前公布与辉瑞就PD-1/VEGF双特异性抗体达成中国以外的全球许可转让合作，交易包括12.5亿美元(下同)的许可首付款付款、最多48亿元的里程碑付款，以及双位数百分比的分级销售里程碑付款。此外，辉瑞可能会认购价值1亿元的三生制药普通股。该行认为交易规模超出市场预期，将交易前期款项纳入集团2025财年的收入预测，并将SSGJ-707在2029财年之后的海外贡献纳入评估范围，目标价由12.7元上调至21.8元，维持“买入”评级。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205163848553_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205163848553_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1441369/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530"],"gpt_icon":0},{"id":"2537263670","title":"中信里昂：升三生制药(01530)目标价至19.6港元 维持“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2537263670","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537263670?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 13:39","pubTimestamp":1747805960,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信里昂发布研报称，将三生制药(01530)目标价从12.3港元上调59%至19.6港元，将目标市盈率从9.8倍上调至15倍，维持“跑赢大市”评级。报告指，SSGJ-707海外授权终于尘埃落定。该行认为，随着康方生物(09926)AK112在国内获得批准，该资产的风险已大幅降低。该行认为辉瑞是一家强大的海外合作伙伴，因为其拥有丰富的ADC管线资产作为组合疗法候选药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09926","01530"],"gpt_icon":0},{"id":"2537677795","title":"60.5亿美元获三生制药PD-1/VEGF双抗权益，辉瑞这次真急了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2537677795","media":"医药经济报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537677795?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 13:07","pubTimestamp":1747804064,"startTime":"0","endTime":"0","summary":"5月20日，三生制药宣布与辉瑞达成一项总额高达60.5亿美元的授权协议，将其自主研发的PD-1/VEGF双特异性抗体SSGJ-707的全球开发、生产和商业化权益独家授予辉瑞，同时保留中国内地的权益。此次合作，无疑给三生制药提供了强有力的发展引擎，再次验证PD-1/VEGF双抗药物同时靶向PD-1和VEGF两大肿瘤靶点的成功，引起了肿瘤界更广泛的关注，成为MNC辉瑞、罗氏、默沙东等肿瘤研发领域的新宠儿。本次与三生制药的合作，并非辉瑞首次布局PD-1/VEGF双抗赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521130927a6e6e679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521130927a6e6e679&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1583","BK1161","BK1593"],"gpt_icon":1},{"id":"2537677322","title":"三生制药：60 亿美元交易，目标价上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2537677322","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537677322?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 12:42","pubTimestamp":1747802565,"startTime":"0","endTime":"0","summary":"【5 月 21 日，招商证券国际报告称，三生制药与辉瑞达成中国生物制药行业最大单一资产交易，预付款 12.5 亿美元，总规模达 60 亿美元。基于公司产品线丰富，目标今年至 2027 年推出约 10 款产品并提交新药申请，持续扩展适应症，内部新型产品线和经验证业务拓展努力使脱发、皮肤病、自体免疫产品组合得以充实。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至 25 港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052112503394fd805e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052112503394fd805e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530"],"gpt_icon":1},{"id":"2537267474","title":"【大行评级丨招商证券国际：上调三生制药目标价至25港元 维持“买入”评级】招商证券国际报告指，三生制药与辉瑞签署中国生物制药行业最大单一资产交易，预付款12.5亿美元，总规模60亿美元。报告指，该行于早前报告已提醒投资者关于PD-1xVEGF和TL1A的许可转让，预计免疫学资产的进一步成熟可能推动另一次估值升级，基于公司产品线丰富，目标今年至2027年推出约10款产品并提交新药申请，并持续扩展适应症，以及内部新型产品线和经验证业务拓展努力，脱发、皮肤病、自体免疫产品组合得到充实。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至25港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537267474","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537267474?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 12:13","pubTimestamp":1747800828,"startTime":"0","endTime":"0","summary":"招商证券国际报告指，三生制药与辉瑞签署中国生物制药行业最大单一资产交易，预付款12.5亿美元，总规模60亿美元。报告指，该行于早前报告已提醒投资者关于PD-1xVEGF和TL1A的许可转让，预计免疫学资产的进一步成熟可能推动另一次估值升级，基于公司产品线丰富，目标今年至2027年推出约10款产品并提交新药申请，并持续扩展适应症，以及内部新型产品线和经验证业务拓展努力，脱发、皮肤病、自体免疫产品组合得到充实。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至25港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21121350556709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01177","06099","PD","01530","PFE"],"gpt_icon":0},{"id":"2537674105","title":"港股午评：恒指早间红盘震荡收涨0.53% 生物医药板块延续涨势","url":"https://stock-news.laohu8.com/highlight/detail?id=2537674105","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537674105?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 12:01","pubTimestamp":1747800104,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["HSCEI","600988","02833","159562","300750","09987","LU0039217434.USD","YUMC","HSI","399441","YANG","06693","MCHmain","BK4209","EVS.SI","BYDDY","01211","MHImain","LU0315178854.USD","LU0269904917.USD","01530","HSTECH","002594","JKS","SG9999003461.SGD","81211","HHImain","LU2476274720.SGD","07226","LU0259732245.USD","LU0821914370.USD","LU0516422952.EUR","HYDD.SI","LU0328353924.USD","161726","02057","LU1979443071.USD","513600","LU0359201612.USD","LU2097828805.USD","08496","HSImain","LU0516423174.USD","03750","LU1808992512.USD","LU0326950275.SGD","ZTO","BK1119","LU1580142542.USD"],"gpt_icon":0},{"id":"2537742416","title":"港股午评|恒生指数早盘涨0.53%      生物医药板块持续强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2537742416","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537742416?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 12:00","pubTimestamp":1747800034,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.53%，涨125点；恒生科技指数涨0.43%；恒生生物科技指数涨2.82%。港股早盘成交1193亿港元。医药股早盘继续走强，国内创新药出海势头强劲，恒瑞医药即将登陆港股。宁德时代上市次日再涨超11%， 股价创新高，公司悉数行使超额配股权。康方生物涨超7%，三生制药PD-1双抗出海刷新纪录，公司依沃西战胜K药。先声药业涨超9%，FGFR2b靶点ADC完成Ⅰ期临床首例患者给药，先诺欣近期销量显著增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"81e47d774545ba217a24feab6560fced","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295692.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCEI","HSI","BK1583","01530","BK1593","BK1161","BK4614","02096","399441","YANG","HSTECH","MCHmain","BK1191","513600","HHImain","161726","MHImain","02833"],"gpt_icon":1},{"id":"2537731674","title":"《大行》里昂升三生制药(01530.HK)目标价至19.6元 维持“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2537731674","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537731674?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:55","pubTimestamp":1747799700,"startTime":"0","endTime":"0","summary":"里昂发表报告指，三生制药日前公布，与辉瑞就其突破性PD-1/VEGF双特异性抗体达成中国以外的全球许可转让合作。该行将三生制药2027年收入盈利预测稍为上调1.2%，因预期SSGJ-707于2027年下半年推出。另外，将目标市盈率由9.8倍升至15倍，以把握资产的长期价值，并将目标价格由12.3元升至19.6元，维持“跑赢大市”评级。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190627151657886_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190627151657886_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1441322/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530"],"gpt_icon":1},{"id":"2537674501","title":"《大行》招证国际：三生制药(01530.HK)料受惠免疫学资产成熟 目标价上调至25元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537674501","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537674501?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:45","pubTimestamp":1747799100,"startTime":"0","endTime":"0","summary":"招商证券国际报告指，三生制药与辉瑞签署中国生物制药行业最大单一资产交易，预付款12.5亿美元，总规模60亿美元。此外，公司充裕的现金状况和不断强化的内部研发团队支持转型。该行维持对三生制药“买入”评级，目标价上调至25元。(港股报价延迟最少十五分钟。沽空资料截至 2025-05-20 16:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180509171356379_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180509171356379_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1441320/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530"],"gpt_icon":0},{"id":"2537671512","title":"康方生物早盘涨超7% 三生制药PD-1双抗出海刷新纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2537671512","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537671512?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:18","pubTimestamp":1747797480,"startTime":"0","endTime":"0","summary":"　　康方生物股价上涨7.40%，现报88.50港元，成交额9.88亿港元。　　据每日经济新闻报道，三生制药PD-1双抗出海刷新纪录。青侨阳光基金经理林伟指出，从长期视角来看，PD-1双抗这一赛道市场广阔，容得下三到五家主流药企共同发展，“除了辉瑞，也还有很多其它药企有收购补全PD-1双抗的强烈意愿，也有众多的新兴ADC药企可以合作”。此外，辉瑞在与Summit短暂合作后就下决心重金引进潜在竞品，对PD1/VEGF双抗这一赛道本身也有背书效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-21/doc-inexhwwk8154063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","IE00B5MMRT66.SGD","LU1169589451.USD","IE00B543WZ88.USD","LU0417516571.SGD","09926","LU1794554557.SGD","LU0348784397.USD","LU0348783233.USD","BK1583","01530","LU1720050803.USD","LU1169590202.USD","BK1593","BK1574","PD","LU2488822045.USD","IE00BPRC5H50.USD","BK4023"],"gpt_icon":0},{"id":"2537671495","title":"三生制药与辉瑞达成重磅授权交易，释放PD-1/VEGF的同类最佳潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2537671495","media":"招银国际","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537671495?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:13","pubTimestamp":1747797239,"startTime":"0","endTime":"0","summary":"此外，辉瑞还将在协议生效日认购价值1亿美元的三生制药普通股。维持“买入”评级，认为公司在PD-1/VEGF领域的领先地位将为其带来长期增长动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521113225a6e6ccf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521113225a6e6ccf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE","01530","BK1161","BK1593","BK1583"],"gpt_icon":1},{"id":"2537794236","title":"《股市简讯》香港生物科技指数一度升3.5%，券商称持续看好中国创新药领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2537794236","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537794236?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:11","pubTimestamp":1747797085,"startTime":"0","endTime":"0","summary":"《股市简讯》香港生物科技指数一度升3.5%，券商称持续看好中国创新药领域* 恒生香港上市生物科技指数.HSHKBIO周三盘中一度升3.5%；该指数此前已连续三日收涨。近日券商研报称持续看好中国创新药领域。* 国元证券亦在研报中称，特朗普想要推进的美国药品降价难度很大，也不会对中国的创新药出海造成实质性的影响。中国创新药进入成果兑现阶段，研发进展催化较多，且不受贸易战影响，有望持续作为2025年医药板块投资主线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"305e35af160080a1ff409fd71b17ab9e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nL4T3RT076:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","LU0140636845.USD","LU2328871848.SGD","09966","BK1191","BK1161","SG9999004220.SGD","IE0008369823.USD","LU1951186391.HKD","LU0326950275.SGD","BK1521","BK1588","LU1226288253.USD","LU0067412154.USD","BK1574","02096","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1226287529.USD","LU1152091168.USD","IE0008368742.USD","BK1583","01093","BK1515","LU0307460666.USD","LU1226287875.USD","LU1960683339.HKD","LU0880133367.SGD","LU1807302812.USD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU0072913022.USD","LU1226287792.SGD","01530","LU0588546209.SGD","BK1500","LU1152091754.HKD","BK1593","IE00BZ08YT58.USD","LU1969619763.USD","IE00B543WZ88.USD","IE00B031HY20.USD","IE00B5MMRT66.SGD","LU1226288170.HKD"],"gpt_icon":1},{"id":"2537456676","title":"中国创新药创记录BD交易的背后","url":"https://stock-news.laohu8.com/highlight/detail?id=2537456676","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537456676?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 10:34","pubTimestamp":1747794881,"startTime":"0","endTime":"0","summary":"中国创新药BD出海刷新认知的情节一直在发生。近日，三生制药与辉瑞的一笔天价交易横空出世，后者以12.5亿美元首付款将三生制药的PD-1/VEGF双抗SSGJ-707收入囊中，一举刷新中国创新药对外授权的首付款记录，后续还有48亿美元里程碑付款、辉瑞1亿美元的股份认购可以期待。交易公布当天，三生制药股价应声大涨32%。类似的情节曾在百利天恒上演，从昔日的“无名之辈”到如今的创新药龙头，最关键的契机就是重磅BD交易的催化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521104020a4861c64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521104020a4861c64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","01530","06978","BK1161","BK1574"],"gpt_icon":1},{"id":"2537491671","title":"三生制药创新合作释放增长潜力：双抗授权与核心品种驱动未来业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2537491671","media":"报告大厅","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537491671?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 10:30","pubTimestamp":1747794635,"startTime":"0","endTime":"0","summary":"近日，三生制药在肿瘤免疫领域取得重要进展，其PD-1/VEGF双特异性抗体的全球权益合作引发市场关注，叠加核心产品特比澳的稳健增长与丰富研发管线支撑，公司正加速进入创新驱动发展的新阶段。总结此次PD-1/VEGF双抗的国际合作标志着三生制药在创新药出海与价值转化领域的突破性进展，叠加核心品种特比澳的持续放量及多元管线支撑，公司未来业绩增长路径清晰可期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052111251594fd6cc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052111251594fd6cc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","BK1583","01530"],"gpt_icon":1},{"id":"2537679679","title":"三生制药签下60亿美元大单，创新药概念今日延续强势，创新药沪港深ETF再度上涨超1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537679679","media":"21世纪经济报道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537679679?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 10:20","pubTimestamp":1747794018,"startTime":"0","endTime":"0","summary":"5月21日，A股三大指数集体上涨，创新药概念延续强势。相关ETF方面，生物医药ETF截至发稿涨0.85%，成交额超2876万元，换手率0.83%，盘中交投活跃。创新药沪港深ETF截至发稿涨1.52%，换手率0.49%。根据协议，三生制药将获得12.5亿美元首付款，以及最高可达48亿美元的开发、监管批准和销售里程碑付款，此次交易的潜在总金额高达60.5亿美元，若按当前汇率计算，潜在总交易金额超过430亿元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052110582594fd64c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"81e47d774545ba217a24feab6560fced","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052110582594fd64c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","06978","BK1574","BK1593","01530"],"gpt_icon":1},{"id":"2537676581","title":"【券商聚焦】国信证券维持三生制药(01530)“优于大市”评级 指公司自研和引进的管线即将进入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2537676581","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537676581?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 10:16","pubTimestamp":1747793778,"startTime":"0","endTime":"0","summary":"公司拥有稳健的增长和良好的盈利水平，创新药管线进度较快，自研和引进的管线即将进入收获期，维持“优于大市”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959031","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","002736"],"gpt_icon":1}],"pageSize":20,"totalPage":19,"pageCount":5,"totalSize":369,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01530\",params:#limit:5,,,undefined,":[{"date":"2025-07-21","symbol":"01530","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-07-22","defaultRemindTime":1753061400000,"name":"三生制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-15","payableDate":"2025-07-22","currency":"HKD","dateTimestamp":1753027200000,"payDate":"2025-08-15"},{"date":"2025-03-25","symbol":"01530","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盘后","dateTimestamp":1742832000000,"actualEps":null},{"date":"2024-08-22","symbol":"01530","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724290200000,"name":null,"time":"盘后","dateTimestamp":1724256000000,"actualEps":null},{"date":"2024-07-22","symbol":"01530","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-07-23","defaultRemindTime":1721611800000,"name":"三生制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-05","payableDate":"2024-07-23","currency":"HKD","dateTimestamp":1721577600000,"payDate":"2024-08-05"},{"date":"2024-03-20","symbol":"01530","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710898200000,"name":null,"time":"","dateTimestamp":1710864000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01530\",market:\"HK\",,,undefined,":[{"executeDate":"2018-06-29","recordDate":"2018-07-03","paymentDate":"2018-07-30","value":0.0685,"currency":"HKD"},{"executeDate":"2022-06-27","recordDate":null,"paymentDate":"2022-07-11","value":0.2,"currency":"HKD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-07-11","value":0.1,"currency":"HKD"},{"executeDate":"2024-07-22","recordDate":"2024-07-23","paymentDate":"2024-08-05","value":0.25,"currency":"HKD"},{"executeDate":"2025-07-21","recordDate":"2025-07-22","paymentDate":"2025-08-15","value":0.25,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01530\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1743436800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01530\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01530","date":"2025-06-10","current":24.784779,"percent":0.975649,"low":5.649976,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"high":32.616228,"avg":11.364886,"sd":4.892589,"marketCap":56616749376},"quantilePoints":[{"date":"2020-06-12","current":23.42378,"twenty":18.526671,"median":21.15283,"eighty":23.078763,"marketCap":24953490702},{"date":"2020-06-19","current":24.166148,"twenty":18.725986,"median":21.165106,"eighty":23.180118,"marketCap":25791273101},{"date":"2020-06-26","current":23.521449,"twenty":18.857418,"median":21.239972,"eighty":23.274524,"marketCap":25080489984},{"date":"2020-07-03","current":25.57706,"twenty":18.977388,"median":21.380685,"eighty":23.420556,"marketCap":27314379780},{"date":"2020-07-10","current":30.04465,"twenty":19.199234,"median":21.624268,"eighty":23.509061,"marketCap":32391402044},{"date":"2020-07-17","current":28.351386,"twenty":19.230471,"median":21.784542,"eighty":23.606481,"marketCap":30614444251},{"date":"2020-07-24","current":23.553786,"twenty":19.27601,"median":22.03771,"eighty":23.717778,"marketCap":25334341097},{"date":"2020-07-31","current":22.146262,"twenty":19.32458,"median":22.148181,"eighty":23.68653,"marketCap":23960240990},{"date":"2020-08-07","current":21.582253,"twenty":19.371354,"median":22.156771,"eighty":23.668161,"marketCap":23375224490},{"date":"2020-08-14","current":21.996768,"twenty":19.461546,"median":22.116274,"eighty":23.608902,"marketCap":23883934490},{"date":"2020-08-21","current":15.787091,"twenty":19.230471,"median":21.995933,"eighty":23.551365,"marketCap":23960240990},{"date":"2020-08-28","current":15.880993,"twenty":18.638495,"median":21.901546,"eighty":23.537633,"marketCap":24290902490},{"date":"2020-09-04","current":14.882704,"twenty":18.106528,"median":21.649951,"eighty":23.52107,"marketCap":22841078991},{"date":"2020-09-11","current":14.022448,"twenty":17.780133,"median":21.582253,"eighty":23.517767,"marketCap":21543868491},{"date":"2020-09-18","current":14.740426,"twenty":17.521864,"median":21.36606,"eighty":23.509061,"marketCap":22866514491},{"date":"2020-09-25","current":13.585833,"twenty":16.548516,"median":21.256355,"eighty":23.498133,"marketCap":20907980991},{"date":"2020-09-30","current":14.344092,"twenty":15.930965,"median":21.216374,"eighty":23.483967,"marketCap":22180200711},{"date":"2020-10-09","current":13.848614,"twenty":15.735354,"median":21.159797,"eighty":23.461821,"marketCap":21722352531},{"date":"2020-10-16","current":13.189162,"twenty":15.378469,"median":21.131217,"eighty":23.430517,"marketCap":20679476121},{"date":"2020-10-23","current":12.391258,"twenty":15.269647,"median":21.000337,"eighty":23.410882,"marketCap":19458547642},{"date":"2020-10-30","current":11.676755,"twenty":14.998865,"median":20.979347,"eighty":23.363794,"marketCap":18339363202},{"date":"2020-11-06","current":11.877973,"twenty":14.690017,"median":20.896428,"eighty":23.30781,"marketCap":18873519412},{"date":"2020-11-13","current":12.011956,"twenty":14.427697,"median":20.722924,"eighty":23.266795,"marketCap":19102443502},{"date":"2020-11-20","current":12.048361,"twenty":14.333539,"median":20.418285,"eighty":23.20982,"marketCap":19280495572},{"date":"2020-11-27","current":11.869467,"twenty":14.243444,"median":20.277362,"eighty":23.180118,"marketCap":18949827442},{"date":"2020-12-04","current":11.863764,"twenty":14.007178,"median":20.215131,"eighty":23.163809,"marketCap":19077007492},{"date":"2020-12-11","current":10.813991,"twenty":13.879087,"median":19.748525,"eighty":23.152109,"marketCap":17347358813},{"date":"2020-12-18","current":11.746326,"twenty":13.824927,"median":19.678609,"eighty":23.150166,"marketCap":18873519412},{"date":"2020-12-24","current":11.512821,"twenty":13.346896,"median":19.553409,"eighty":23.133368,"marketCap":18517415272},{"date":"2020-12-31","current":11.176142,"twenty":12.885666,"median":19.399862,"eighty":23.103596,"marketCap":17983259062},{"date":"2021-01-08","current":10.951057,"twenty":10.975298,"median":11.176142,"eighty":11.338002,"marketCap":17779770983},{"date":"2021-01-15","current":10.903863,"twenty":10.829347,"median":10.989897,"eighty":11.324423,"marketCap":17678026943},{"date":"2021-01-22","current":11.96006,"twenty":10.893666,"median":11.138396,"eighty":11.457272,"marketCap":19382239612},{"date":"2021-01-29","current":11.254884,"twenty":10.919998,"median":11.285586,"eighty":11.564584,"marketCap":18390235222},{"date":"2021-02-05","current":12.685187,"twenty":10.942936,"median":11.340068,"eighty":11.943922,"marketCap":20603168091},{"date":"2021-02-11","current":12.46373,"twenty":10.965968,"median":11.447067,"eighty":12.289931,"marketCap":20272499962},{"date":"2021-02-19","current":13.708813,"twenty":10.98896,"median":11.531282,"eighty":12.474049,"marketCap":22307380761},{"date":"2021-02-26","current":12.09409,"twenty":11.020846,"median":11.810324,"eighty":12.771417,"marketCap":19636599712},{"date":"2021-03-05","current":11.747557,"twenty":11.145945,"median":11.933164,"eighty":12.661366,"marketCap":19026135472},{"date":"2021-03-12","current":11.673762,"twenty":11.145945,"median":11.764748,"eighty":12.557433,"marketCap":18873519412},{"date":"2021-03-19","current":11.567481,"twenty":11.19189,"median":11.778346,"eighty":12.517269,"marketCap":18695467342},{"date":"2021-03-26","current":10.891613,"twenty":11.117482,"median":11.684905,"eighty":12.493731,"marketCap":17525410883},{"date":"2021-04-01","current":17.985497,"twenty":11.112253,"median":11.721802,"eighty":12.56608,"marketCap":17805206993},{"date":"2021-04-09","current":18.432989,"twenty":11.127939,"median":11.778346,"eighty":12.807919,"marketCap":18288491182},{"date":"2021-04-16","current":17.862157,"twenty":11.161044,"median":11.865003,"eighty":13.241029,"marketCap":17789234973},{"date":"2021-04-23","current":19.042838,"twenty":11.223387,"median":11.933164,"eighty":15.47132,"marketCap":19012563452},{"date":"2021-04-30","current":18.710444,"twenty":11.277395,"median":12.054991,"eighty":17.868836,"marketCap":18757703352},{"date":"2021-05-07","current":17.554408,"twenty":11.306734,"median":12.256451,"eighty":17.915192,"marketCap":17712776943},{"date":"2021-05-14","current":19.436163,"twenty":11.316587,"median":12.453788,"eighty":17.999619,"marketCap":19598741682},{"date":"2021-05-21","current":19.607681,"twenty":11.324722,"median":12.482713,"eighty":18.355798,"marketCap":19777143752},{"date":"2021-05-28","current":22.268767,"twenty":11.338002,"median":12.522845,"eighty":18.529646,"marketCap":22682548891},{"date":"2021-06-04","current":23.506716,"twenty":11.345592,"median":12.739081,"eighty":18.831667,"marketCap":23829989690},{"date":"2021-06-11","current":26.450129,"twenty":11.384641,"median":12.957551,"eighty":19.026489,"marketCap":26811924229},{"date":"2021-06-18","current":27.883097,"twenty":11.434041,"median":13.165771,"eighty":19.07752,"marketCap":28035281989},{"date":"2021-06-25","current":25.719333,"twenty":11.457054,"median":13.641205,"eighty":19.573377,"marketCap":25843432669},{"date":"2021-07-02","current":23.991316,"twenty":11.497003,"median":15.724677,"eighty":20.625755,"marketCap":24064953030},{"date":"2021-07-09","current":21.038896,"twenty":11.531282,"median":17.620941,"eighty":22.268767,"marketCap":21082326436},{"date":"2021-07-16","current":21.649903,"twenty":11.562167,"median":17.801719,"eighty":22.22185,"marketCap":21694147276},{"date":"2021-07-23","current":19.947305,"twenty":11.567481,"median":17.862157,"eighty":22.084791,"marketCap":19986147432},{"date":"2021-07-30","current":16.406492,"twenty":11.59769,"median":17.801719,"eighty":21.788189,"marketCap":16493670138},{"date":"2021-08-06","current":16.802074,"twenty":11.614538,"median":17.743633,"eighty":21.649903,"marketCap":16850565628},{"date":"2021-08-13","current":18.886134,"twenty":11.673762,"median":17.779702,"eighty":21.183606,"marketCap":18966446032},{"date":"2021-08-20","current":17.768797,"twenty":11.696048,"median":17.819034,"eighty":21.038896,"marketCap":17793789423},{"date":"2021-08-27","current":16.692119,"twenty":11.747557,"median":17.801719,"eighty":21.033586,"marketCap":20735050481},{"date":"2021-09-03","current":17.466007,"twenty":11.778346,"median":17.768797,"eighty":20.834949,"marketCap":21705193951},{"date":"2021-09-10","current":17.537221,"twenty":11.781939,"median":17.749396,"eighty":20.79403,"marketCap":21849743511},{"date":"2021-09-17","current":16.873614,"twenty":11.829513,"median":17.593173,"eighty":20.713648,"marketCap":20960774196},{"date":"2021-09-24","current":15.891613,"twenty":11.886297,"median":17.584775,"eighty":20.643334,"marketCap":19750043557},{"date":"2021-09-30","current":15.474503,"twenty":11.914957,"median":17.537221,"eighty":20.597572,"marketCap":19296019567},{"date":"2021-10-08","current":14.868338,"twenty":11.929738,"median":17.471827,"eighty":20.523384,"marketCap":18539312917},{"date":"2021-10-15","current":14.534703,"twenty":11.943922,"median":17.393521,"eighty":20.409691,"marketCap":18135736037},{"date":"2021-10-22","current":15.254007,"twenty":11.992262,"median":17.164588,"eighty":20.155654,"marketCap":19169901792},{"date":"2021-10-29","current":14.32602,"twenty":12.052106,"median":16.901646,"eighty":19.822619,"marketCap":17959171152},{"date":"2021-11-05","current":13.860523,"twenty":12.079287,"median":16.802074,"eighty":19.624426,"marketCap":17404252943},{"date":"2021-11-12","current":14.383763,"twenty":12.159034,"median":16.779243,"eighty":19.588676,"marketCap":18135736037},{"date":"2021-11-19","current":13.622836,"twenty":12.278771,"median":16.568761,"eighty":19.510566,"marketCap":17152017393},{"date":"2021-11-26","current":13.298043,"twenty":12.364889,"median":16.431408,"eighty":19.425837,"marketCap":16748440513},{"date":"2021-12-03","current":13.533375,"twenty":12.451799,"median":16.380162,"eighty":19.304184,"marketCap":17076346728},{"date":"2021-12-10","current":13.530262,"twenty":12.46889,"median":15.9828,"eighty":19.12088,"marketCap":17101570283},{"date":"2021-12-17","current":13.559592,"twenty":12.481497,"median":15.474503,"eighty":19.070251,"marketCap":17126793838},{"date":"2021-12-24","current":13.187537,"twenty":12.491264,"median":15.316496,"eighty":19.046201,"marketCap":16672769848},{"date":"2021-12-31","current":12.939931,"twenty":12.50054,"median":15.276462,"eighty":19.041674,"marketCap":16395310743},{"date":"2022-01-07","current":12.629546,"twenty":12.669271,"median":12.939931,"eighty":13.294377,"marketCap":15941286753},{"date":"2022-01-14","current":13.31994,"twenty":12.739596,"median":13.158397,"eighty":13.389669,"marketCap":16849334733},{"date":"2022-01-21","current":13.110466,"twenty":12.821107,"median":13.146404,"eighty":13.374152,"marketCap":16622322738},{"date":"2022-01-28","current":11.290609,"twenty":12.592795,"median":13.025199,"eighty":13.33992,"marketCap":14278449114},{"date":"2022-02-04","current":11.73951,"twenty":11.988397,"median":12.937634,"eighty":13.31994,"marketCap":14838866059},{"date":"2022-02-11","current":12.600787,"twenty":11.988397,"median":12.895764,"eighty":13.209556,"marketCap":15959699948},{"date":"2022-02-18","current":12.386052,"twenty":12.386052,"median":12.812393,"eighty":13.193339,"marketCap":15764772315},{"date":"2022-02-25","current":11.935463,"twenty":11.988397,"median":12.695755,"eighty":13.170389,"marketCap":15228721325},{"date":"2022-03-04","current":11.339121,"twenty":11.902053,"median":12.615167,"eighty":13.146404,"marketCap":14473376747},{"date":"2022-03-11","current":10.811811,"twenty":11.786733,"median":12.537668,"eighty":13.131086,"marketCap":13779476577},{"date":"2022-03-18","current":11.43147,"twenty":11.43147,"median":12.408169,"eighty":13.110466,"marketCap":14511130201},{"date":"2022-03-25","current":11.488626,"twenty":11.433439,"median":12.316063,"eighty":13.033248,"marketCap":14584295563},{"date":"2022-04-01","current":7.736942,"twenty":11.290609,"median":12.024306,"eighty":12.939931,"marketCap":15730552907},{"date":"2022-04-08","current":7.901451,"twenty":10.775992,"median":11.96193,"eighty":12.936256,"marketCap":16071991265},{"date":"2022-04-14","current":7.650324,"twenty":9.945202,"median":11.917347,"eighty":12.911593,"marketCap":15535445274},{"date":"2022-04-22","current":6.804709,"twenty":7.91723,"median":11.900612,"eighty":12.888104,"marketCap":13559980490},{"date":"2022-04-29","current":6.903581,"twenty":7.657518,"median":11.816815,"eighty":12.868353,"marketCap":13535592036},{"date":"2022-05-06","current":6.547485,"twenty":7.585282,"median":11.73951,"eighty":12.838535,"marketCap":12730773050},{"date":"2022-05-13","current":7.024374,"twenty":7.5042,"median":11.586418,"eighty":12.768824,"marketCap":13413649766},{"date":"2022-05-20","current":7.191673,"twenty":7.191673,"median":11.454736,"eighty":12.716391,"marketCap":13925807302},{"date":"2022-05-27","current":7.00883,"twenty":7.024374,"median":11.35879,"eighty":12.695755,"marketCap":13559980490},{"date":"2022-06-02","current":7.284877,"twenty":7.084601,"median":11.290609,"eighty":12.646528,"marketCap":14169691843},{"date":"2022-06-10","current":8.17995,"twenty":7.134723,"median":10.844875,"eighty":12.630481,"marketCap":15803718269},{"date":"2022-06-17","current":8.201566,"twenty":7.143969,"median":10.575882,"eighty":12.606539,"marketCap":15828106723},{"date":"2022-06-24","current":8.408197,"twenty":7.145307,"median":9.539707,"eighty":12.573046,"marketCap":16291487352},{"date":"2022-06-30","current":7.86791,"twenty":7.173248,"median":8.407756,"eighty":12.549045,"marketCap":15218395370},{"date":"2022-07-08","current":7.708668,"twenty":7.192307,"median":8.255051,"eighty":12.514413,"marketCap":14925733921},{"date":"2022-07-15","current":7.119666,"twenty":7.192049,"median":8.186646,"eighty":12.444606,"marketCap":13657534307},{"date":"2022-07-22","current":7.292873,"twenty":7.192558,"median":8.134372,"eighty":12.408122,"marketCap":13998972664},{"date":"2022-07-29","current":6.624114,"twenty":7.143849,"median":8.058514,"eighty":12.394805,"marketCap":12730773050},{"date":"2022-08-05","current":6.679196,"twenty":7.108037,"median":8.01541,"eighty":12.344059,"marketCap":12803938413},{"date":"2022-08-12","current":6.746336,"twenty":7.015964,"median":7.902917,"eighty":12.241829,"marketCap":12950269137},{"date":"2022-08-19","current":6.506545,"twenty":6.904437,"median":7.849319,"eighty":12.101006,"marketCap":12364946238},{"date":"2022-08-26","current":6.444966,"twenty":6.85354,"median":7.765995,"eighty":12.021144,"marketCap":12560053871},{"date":"2022-09-02","current":6.75706,"twenty":6.802523,"median":7.70872,"eighty":11.996437,"marketCap":13120988316},{"date":"2022-09-09","current":7.186325,"twenty":6.782371,"median":7.676298,"eighty":11.956637,"marketCap":13901418848},{"date":"2022-09-16","current":7.037021,"twenty":6.773934,"median":7.658948,"eighty":11.933229,"marketCap":13486815128},{"date":"2022-09-23","current":7.278546,"twenty":6.801431,"median":7.629045,"eighty":11.919853,"marketCap":13681922761},{"date":"2022-09-30","current":7.21287,"twenty":6.812093,"median":7.563431,"eighty":11.90371,"marketCap":13584368944},{"date":"2022-10-07","current":8.495359,"twenty":6.827071,"median":7.601693,"eighty":11.901476,"marketCap":15998825902},{"date":"2022-10-14","current":7.866533,"twenty":6.84454,"median":7.6518,"eighty":11.887944,"marketCap":14657460926},{"date":"2022-10-21","current":7.65719,"twenty":6.852519,"median":7.654495,"eighty":11.837793,"marketCap":14169691843},{"date":"2022-10-28","current":7.485499,"twenty":6.854712,"median":7.648155,"eighty":11.810799,"marketCap":13828253486},{"date":"2022-11-04","current":7.71408,"twenty":6.855543,"median":7.64924,"eighty":11.777288,"marketCap":14389187930},{"date":"2022-11-11","current":9.447275,"twenty":6.857645,"median":7.65719,"eighty":11.716902,"marketCap":17779183053},{"date":"2022-11-18","current":8.946595,"twenty":6.869919,"median":7.676298,"eighty":11.61846,"marketCap":16779256434},{"date":"2022-11-25","current":10.591073,"twenty":6.900487,"median":7.708668,"eighty":11.56686,"marketCap":19705870928},{"date":"2022-12-02","current":10.475811,"twenty":6.903866,"median":7.7222,"eighty":11.486108,"marketCap":19827813199},{"date":"2022-12-09","current":10.787939,"twenty":6.908551,"median":7.756461,"eighty":11.467515,"marketCap":20608243731},{"date":"2022-12-16","current":10.467652,"twenty":6.922758,"median":7.825152,"eighty":11.433045,"marketCap":19949755470},{"date":"2022-12-23","current":10.605113,"twenty":6.925733,"median":7.866533,"eighty":11.416934,"marketCap":20218028465},{"date":"2022-12-30","current":10.490454,"twenty":6.934226,"median":7.88468,"eighty":11.373326,"marketCap":20242416919},{"date":"2023-01-06","current":10.709162,"twenty":6.946262,"median":7.911832,"eighty":11.346989,"marketCap":20876730726},{"date":"2023-01-13","current":10.409987,"twenty":6.967625,"median":7.940898,"eighty":11.310014,"marketCap":20681621093},{"date":"2023-01-20","current":10.970611,"twenty":6.992171,"median":8.025256,"eighty":11.115951,"marketCap":21608391850},{"date":"2023-01-27","current":11.178822,"twenty":7.001767,"median":8.04566,"eighty":11.178822,"marketCap":22022999820},{"date":"2023-02-03","current":10.333228,"twenty":7.00883,"median":8.080352,"eighty":11.042599,"marketCap":20462542256},{"date":"2023-02-10","current":10.432866,"twenty":7.016354,"median":8.128802,"eighty":10.999512,"marketCap":20535709869},{"date":"2023-02-17","current":10.482453,"twenty":7.02072,"median":8.154322,"eighty":10.970611,"marketCap":20438153052},{"date":"2023-02-24","current":10.422238,"twenty":7.023227,"median":8.186646,"eighty":10.901364,"marketCap":20072314990},{"date":"2023-03-03","current":10.103813,"twenty":7.024374,"median":8.255051,"eighty":10.877939,"marketCap":19584530908},{"date":"2023-03-10","current":9.849365,"twenty":9.829083,"median":9.880019,"eighty":9.959262,"marketCap":18950411601},{"date":"2023-03-17","current":10.294831,"twenty":10.851941,"median":19.048443,"eighty":26.326687,"marketCap":19999147378},{"date":"2023-03-24","current":8.629709,"twenty":10.789936,"median":18.976613,"eighty":26.218311,"marketCap":19023579213},{"date":"2023-03-31","current":8.718432,"twenty":10.730721,"median":18.809149,"eighty":26.129947,"marketCap":19072357621},{"date":"2023-04-06","current":8.880244,"twenty":10.716567,"median":18.692825,"eighty":26.082958,"marketCap":19413806479},{"date":"2023-04-14","current":9.049805,"twenty":10.697852,"median":18.558662,"eighty":26.015238,"marketCap":19804033745},{"date":"2023-04-21","current":8.753391,"twenty":10.627861,"median":18.432989,"eighty":25.943189,"marketCap":19145525234},{"date":"2023-04-28","current":8.819057,"twenty":10.598903,"median":18.271485,"eighty":25.849308,"marketCap":19145525234},{"date":"2023-05-05","current":8.835413,"twenty":10.581949,"median":18.06906,"eighty":25.740696,"marketCap":19212487419},{"date":"2023-05-12","current":8.252473,"twenty":10.520288,"median":17.98145,"eighty":25.676606,"marketCap":17821321039},{"date":"2023-05-19","current":8.651806,"twenty":10.481672,"median":17.862157,"eighty":25.617372,"marketCap":18420961720},{"date":"2023-05-25","current":9.128719,"twenty":10.4573,"median":17.786098,"eighty":25.551849,"marketCap":19356401182},{"date":"2023-06-02","current":8.88737,"twenty":10.414887,"median":17.743633,"eighty":25.442824,"marketCap":18780746128},{"date":"2023-06-09","current":8.684241,"twenty":10.379693,"median":17.593173,"eighty":25.321673,"marketCap":18325019211},{"date":"2023-06-16","current":8.497602,"twenty":10.298226,"median":17.536423,"eighty":25.234525,"marketCap":17845306666},{"date":"2023-06-23","current":8.314521,"twenty":10.235267,"median":17.466007,"eighty":25.17103,"marketCap":17365594121},{"date":"2023-06-30","current":9.120524,"twenty":10.102258,"median":17.164588,"eighty":25.018734,"marketCap":18876688637},{"date":"2023-07-07","current":8.464877,"twenty":10.024021,"median":16.874069,"eighty":24.903693,"marketCap":17485522257},{"date":"2023-07-14","current":8.313385,"twenty":9.8931,"median":16.779243,"eighty":24.834872,"marketCap":17413565376},{"date":"2023-07-21","current":8.50176,"twenty":9.81238,"median":16.464583,"eighty":24.737115,"marketCap":17725378530},{"date":"2023-07-28","current":8.672104,"twenty":9.353435,"median":16.177564,"eighty":24.675112,"marketCap":18061177311},{"date":"2023-08-04","current":8.358775,"twenty":9.161002,"median":15.883244,"eighty":24.577585,"marketCap":17437551003},{"date":"2023-08-11","current":8.117166,"twenty":9.070765,"median":15.513441,"eighty":24.497368,"marketCap":16837910322},{"date":"2023-08-18","current":7.942776,"twenty":9.010529,"median":15.366608,"eighty":24.346619,"marketCap":16358197777},{"date":"2023-08-25","current":7.720715,"twenty":8.968684,"median":15.291628,"eighty":24.251918,"marketCap":16022398996},{"date":"2023-09-01","current":7.55067,"twenty":8.931187,"median":15.199326,"eighty":24.160656,"marketCap":15734571469},{"date":"2023-09-08","current":7.780387,"twenty":8.882813,"median":14.999167,"eighty":24.077684,"marketCap":16022398996},{"date":"2023-09-15","current":8.044139,"twenty":8.832795,"median":14.893474,"eighty":24.001187,"marketCap":16693996559},{"date":"2023-09-22","current":7.800863,"twenty":8.805502,"median":14.827905,"eighty":23.891521,"marketCap":16118341505},{"date":"2023-09-29","current":7.590502,"twenty":8.767962,"median":14.58488,"eighty":23.787271,"marketCap":15710585842},{"date":"2023-10-06","current":7.594139,"twenty":8.732701,"median":14.497234,"eighty":23.749161,"marketCap":15710585842},{"date":"2023-10-13","current":7.802894,"twenty":8.680502,"median":14.383763,"eighty":23.669452,"marketCap":16118341505},{"date":"2023-10-20","current":7.396278,"twenty":8.651836,"median":14.296719,"eighty":23.61072,"marketCap":15254858924},{"date":"2023-10-27","current":7.620505,"twenty":8.636311,"median":14.231462,"eighty":23.563756,"marketCap":15710585842},{"date":"2023-11-03","current":8.238519,"twenty":8.593268,"median":14.135835,"eighty":23.541685,"marketCap":17029795340},{"date":"2023-11-10","current":8.135787,"twenty":8.561489,"median":14.026244,"eighty":23.507495,"marketCap":16813924695},{"date":"2023-11-17","current":8.155085,"twenty":8.521038,"median":13.963498,"eighty":23.459416,"marketCap":17005809713},{"date":"2023-11-24","current":8.53342,"twenty":8.497153,"median":13.860523,"eighty":23.39518,"marketCap":17941249175},{"date":"2023-12-01","current":8.532266,"twenty":8.455902,"median":13.824815,"eighty":23.33521,"marketCap":18013206057},{"date":"2023-12-08","current":8.167635,"twenty":8.416427,"median":13.708813,"eighty":23.268697,"marketCap":17173709103},{"date":"2023-12-15","current":8.120741,"twenty":8.372891,"median":13.573597,"eighty":23.268697,"marketCap":17173709103},{"date":"2023-12-22","current":7.547349,"twenty":8.340139,"median":13.445935,"eighty":23.268697,"marketCap":15950442114},{"date":"2023-12-29","current":8.489483,"twenty":8.333442,"median":13.401057,"eighty":23.268697,"marketCap":18037191684},{"date":"2024-01-05","current":7.958572,"twenty":8.311899,"median":13.353915,"eighty":23.268697,"marketCap":16789939068},{"date":"2024-01-12","current":7.522531,"twenty":8.274788,"median":13.298043,"eighty":23.268697,"marketCap":15878485232},{"date":"2024-01-19","current":6.838761,"twenty":8.246837,"median":13.193339,"eighty":23.218433,"marketCap":14415361971},{"date":"2024-01-26","current":6.751245,"twenty":8.199921,"median":13.152876,"eighty":23.153426,"marketCap":14175505698},{"date":"2024-02-02","current":6.645484,"twenty":8.178106,"median":13.103765,"eighty":23.113627,"marketCap":13935649426},{"date":"2024-02-09","current":6.464952,"twenty":8.160603,"median":13.048718,"eighty":23.081073,"marketCap":13623836272},{"date":"2024-02-16","current":6.270103,"twenty":8.153092,"median":12.964057,"eighty":23.031568,"marketCap":13216080609},{"date":"2024-02-23","current":6.154614,"twenty":8.12992,"median":12.866288,"eighty":22.958247,"marketCap":12904267455},{"date":"2024-03-01","current":6.425162,"twenty":8.119907,"median":12.768824,"eighty":22.855959,"marketCap":13479922508},{"date":"2024-03-08","current":5.668086,"twenty":8.106269,"median":12.685187,"eighty":22.664212,"marketCap":11896871111},{"date":"2024-03-15","current":5.970488,"twenty":8.087,"median":12.56608,"eighty":22.617544,"marketCap":12520497419},{"date":"2024-03-22","current":6.800223,"twenty":8.057136,"median":12.488798,"eighty":22.572752,"marketCap":14247462580},{"date":"2024-03-28","current":6.865119,"twenty":8.03691,"median":12.408404,"eighty":22.491655,"marketCap":14337425089},{"date":"2024-04-05","current":6.930569,"twenty":8.010866,"median":12.314157,"eighty":22.381231,"marketCap":14464581272},{"date":"2024-04-12","current":8.487739,"twenty":7.986804,"median":12.230754,"eighty":22.341312,"marketCap":14238321582},{"date":"2024-04-19","current":7.902573,"twenty":7.973424,"median":12.09409,"eighty":22.231233,"marketCap":13245377965},{"date":"2024-04-26","current":8.651786,"twenty":7.971703,"median":12.040613,"eighty":22.147797,"marketCap":14483242321},{"date":"2024-05-03","current":9.683032,"twenty":7.971703,"median":12.008496,"eighty":22.084093,"marketCap":16198363123},{"date":"2024-05-10","current":9.574862,"twenty":7.971703,"median":11.96006,"eighty":21.996434,"marketCap":16055436389},{"date":"2024-05-17","current":9.031812,"twenty":7.971703,"median":11.9246,"eighty":21.943927,"marketCap":15122602622},{"date":"2024-05-24","current":8.723102,"twenty":7.971703,"median":11.884599,"eighty":21.824145,"marketCap":14572351730},{"date":"2024-05-31","current":8.683193,"twenty":7.971703,"median":11.86257,"eighty":21.670633,"marketCap":14520444416},{"date":"2024-06-07","current":8.98585,"twenty":7.971703,"median":11.808963,"eighty":21.649887,"marketCap":15007926263},{"date":"2024-06-14","current":8.927337,"twenty":7.971703,"median":11.78311,"eighty":21.558611,"marketCap":14896537014},{"date":"2024-06-21","current":8.653958,"twenty":7.971703,"median":11.748959,"eighty":21.341418,"marketCap":14410135834},{"date":"2024-06-28","current":9.147662,"twenty":7.971703,"median":11.696048,"eighty":21.190941,"marketCap":15225906682},{"date":"2024-07-05","current":9.12874,"twenty":7.971703,"median":11.667775,"eighty":21.154306,"marketCap":15191112394},{"date":"2024-07-12","current":9.553452,"twenty":7.971703,"median":11.586418,"eighty":21.030296,"marketCap":15921227874},{"date":"2024-07-19","current":9.270632,"twenty":7.971703,"median":11.512821,"eighty":20.905813,"marketCap":15450185629},{"date":"2024-07-26","current":8.673146,"twenty":7.971703,"median":11.447067,"eighty":20.788718,"marketCap":14508131939},{"date":"2024-08-02","current":8.63594,"twenty":7.971703,"median":11.35879,"eighty":20.681196,"marketCap":14437475453},{"date":"2024-08-09","current":8.676727,"twenty":7.971703,"median":11.316787,"eighty":20.443888,"marketCap":14602340588},{"date":"2024-08-16","current":9.093035,"twenty":7.971703,"median":11.187378,"eighty":20.269083,"marketCap":15308905456},{"date":"2024-08-23","current":7.455797,"twenty":7.968286,"median":11.053511,"eighty":19.744503,"marketCap":13495388963},{"date":"2024-08-30","current":7.832605,"twenty":7.94319,"median":10.97804,"eighty":19.603864,"marketCap":14272610317},{"date":"2024-09-06","current":7.54462,"twenty":7.922419,"median":10.903863,"eighty":19.431,"marketCap":13754462748},{"date":"2024-09-13","current":7.305365,"twenty":7.904466,"median":10.877939,"eighty":19.216074,"marketCap":13283419503},{"date":"2024-09-20","current":7.339071,"twenty":7.881443,"median":10.812901,"eighty":19.042838,"marketCap":13424732476},{"date":"2024-09-27","current":8.203896,"twenty":7.851675,"median":10.750241,"eighty":18.92333,"marketCap":15096935995},{"date":"2024-10-04","current":9.501316,"twenty":7.851675,"median":10.719171,"eighty":18.804822,"marketCap":17405047895},{"date":"2024-10-10","current":8.812673,"twenty":7.854647,"median":10.700045,"eighty":18.679274,"marketCap":16039022485},{"date":"2024-10-18","current":8.416572,"twenty":7.851675,"median":10.633669,"eighty":18.484377,"marketCap":15238248969},{"date":"2024-10-25","current":8.130899,"twenty":7.851675,"median":10.60446,"eighty":18.375861,"marketCap":14720101400},{"date":"2024-11-01","current":7.618395,"twenty":7.837145,"median":10.583466,"eighty":18.158058,"marketCap":13801567072},{"date":"2024-11-08","current":7.940429,"twenty":7.812932,"median":10.521849,"eighty":18.004775,"marketCap":14319714641},{"date":"2024-11-15","current":7.616222,"twenty":7.800863,"median":10.481803,"eighty":17.930901,"marketCap":13589597612},{"date":"2024-11-22","current":7.289682,"twenty":7.7868,"median":10.43732,"eighty":17.787791,"marketCap":13000793556},{"date":"2024-11-29","current":7.558871,"twenty":7.756696,"median":10.406034,"eighty":17.75516,"marketCap":13471836801},{"date":"2024-12-06","current":8.19928,"twenty":7.756461,"median":10.371434,"eighty":17.593173,"marketCap":14578788426},{"date":"2024-12-13","current":8.162406,"twenty":7.756461,"median":10.287916,"eighty":17.536423,"marketCap":14484579777},{"date":"2024-12-20","current":8.065423,"twenty":7.756461,"median":10.197205,"eighty":17.447722,"marketCap":14249058155},{"date":"2024-12-27","current":7.911585,"twenty":7.756461,"median":10.12095,"eighty":17.361184,"marketCap":13966432208},{"date":"2025-01-03","current":7.87719,"twenty":7.756461,"median":10.036539,"eighty":16.928768,"marketCap":13919327883},{"date":"2025-01-10","current":7.612806,"twenty":7.740892,"median":10.004547,"eighty":16.790663,"marketCap":13401180314},{"date":"2025-01-17","current":8.28846,"twenty":7.730321,"median":9.838221,"eighty":16.516863,"marketCap":14602340588},{"date":"2025-01-24","current":8.157137,"twenty":7.730321,"median":9.650996,"eighty":16.380162,"marketCap":14461027615},{"date":"2025-01-28","current":7.942804,"twenty":7.731645,"median":9.603098,"eighty":16.23971,"marketCap":14154849506},{"date":"2025-02-07","current":8.546227,"twenty":7.72951,"median":9.447275,"eighty":15.827107,"marketCap":15144040320},{"date":"2025-02-14","current":8.966376,"twenty":7.72951,"median":9.349312,"eighty":15.479298,"marketCap":15850605187},{"date":"2025-02-21","current":9.142724,"twenty":7.72951,"median":9.31673,"eighty":15.341254,"marketCap":16250991945},{"date":"2025-02-28","current":9.757898,"twenty":7.72951,"median":9.275627,"eighty":15.286311,"marketCap":17287287084},{"date":"2025-03-07","current":10.023419,"twenty":7.728699,"median":9.273129,"eighty":15.091756,"marketCap":17828986815},{"date":"2025-03-14","current":12.825839,"twenty":7.728699,"median":9.273129,"eighty":14.95492,"marketCap":22822045210},{"date":"2025-03-21","current":13.665083,"twenty":7.728699,"median":9.273129,"eighty":14.886108,"marketCap":24305831431},{"date":"2025-03-28","current":12.928275,"twenty":7.728699,"median":9.273129,"eighty":14.825099,"marketCap":28922055230},{"date":"2025-04-03","current":13.892013,"twenty":7.728699,"median":9.273129,"eighty":14.555799,"marketCap":31088854156},{"date":"2025-04-11","current":13.167923,"twenty":7.728699,"median":9.273129,"eighty":14.420765,"marketCap":29204681177},{"date":"2025-04-17","current":12.670277,"twenty":7.72951,"median":9.275627,"eighty":14.377837,"marketCap":28168386039},{"date":"2025-04-25","current":13.794908,"twenty":7.727888,"median":9.270632,"eighty":14.256721,"marketCap":30695134656},{"date":"2025-05-02","current":14.188557,"twenty":7.728699,"median":9.273129,"eighty":14.229301,"marketCap":31638149546},{"date":"2025-05-09","current":12.682782,"twenty":7.727888,"median":9.270632,"eighty":14.162597,"marketCap":28479049665},{"date":"2025-05-16","current":13.271183,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":30043763873},{"date":"2025-05-23","current":20.823678,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":47282375641},{"date":"2025-05-30","current":19.460658,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":44381761075},{"date":"2025-06-06","current":20.841619,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":47652430724},{"date":"2025-06-10","current":24.784779,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":56616749376}],"updateTime":1749642322722}}}